Adams Diversified Equity Fund’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Hold |
19,700
| – | – | 0.37% | 83 |
|
|
2025
Q1 | $12.5M | Sell |
19,700
-2,000
| -9% | -$1.27M | 0.5% | 70 |
|
|
2024
Q4 | $15.5M | Hold |
21,700
| – | – | 0.58% | 58 |
|
|
2024
Q3 | $22.8M | Sell |
21,700
-10,600
| -33% | -$11.1M | 0.84% | 37 |
|
|
2024
Q2 | $33.9M | Hold |
32,300
| – | – | 1.16% | 16 |
|
|
2024
Q1 | $31.1M | Hold |
32,300
| – | – | 1.1% | 23 |
|
|
2023
Q4 | $28.4M | Hold |
32,300
| – | – | 1.12% | 31 |
|
|
2023
Q3 | $26.6M | Buy |
32,300
+12,300
| +62% | +$10.1M | 1.14% | 27 |
|
|
2023
Q2 | $14.4M | Sell |
20,000
-13,500
| -40% | -$9.7M | 0.6% | 70 |
|
|
2023
Q1 | $27.5M | Hold |
33,500
| – | – | 1.24% | 20 |
|
|
2022
Q4 | $24.2M | Buy |
33,500
+2,900
| +9% | +$2.09M | 1.16% | 23 |
|
|
2022
Q3 | $21.1M | Hold |
30,600
| – | – | 1.05% | 28 |
|
|
2022
Q2 | $18.1M | Sell |
30,600
-14,400
| -32% | -$8.51M | 0.86% | 44 |
|
|
2022
Q1 | $31.4M | Buy |
45,000
+14,900
| +50% | +$10.4M | 1.25% | 23 |
|
|
2021
Q4 | $19M | Hold |
30,100
| – | – | 0.72% | 53 |
|
|
2021
Q3 | $18.2M | Buy |
+30,100
| New | +$18.2M | 0.72% | 57 |
|